Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
10/2003
10/02/2003US20030186941 Cyclopenteneone derivatives
10/02/2003US20030186932 Polysaccharides comprising galactose, arabinose, and glucuronic acid units; for treatment of arthritis/inflammation
10/02/2003US20030186905 Cis-acting regulatory nucleic acid sequences in the parathyroid hormone3' -untranslated region
10/02/2003US20030186894 Dry powder compositions having improved dispersivity
10/02/2003US20030186891 Polypeptide comprising fragments of matrix extracellular phosphoglycoproteins used to control calcitriol concentrations in cells, for prophylaxis of bone disorders
10/02/2003US20030186889 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction
10/02/2003US20030186876 IL-6 antagonist peptides
10/02/2003US20030186875 Uses of mammalian cytokine; related reagents
10/02/2003US20030186842 Contacting a cell population with an inhibiting effective amount of a reagent that suppresses the protease activity of at least one member of the interleukin-1beta- converting enzyme (ICE)/CED-3 family
10/02/2003US20030186424 Reagents and methods for identifying and modulating expression of genes regulated by CDK inhibitors
10/02/2003US20030186337 Novel death associated proteins, and THAP1 and PAR4 pathways in apoptosis control
10/02/2003US20030186325 Method of screening for inhibitors of osteopontin
10/02/2003US20030186321 Comprises polypeptide having antitumor, immunomodulatory and viricidal activity for treating leukemia, hepatitis and autoimmune diseases
10/02/2003US20030186308 Prostacyclin-stimulating factor-2
10/02/2003US20030185905 Plant extracts for the treatment of increased bone resorption
10/02/2003US20030185824 Administering an inhibitor of the CD2/LFA-3 interaction, in combination with an auxiliary agent, such as UV-B
10/02/2003US20030185816 Modified immunogenic self-protein and a surfactant capable of acting as a solubiliser, especially modified human TNF alpha and cetylpyridinium chloride
10/02/2003US20030185815 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/02/2003US20030185809 First population of mammalian cells transfected or transduced with a gene that is sought to be expressed, and a second population of mammalian cells that have not been transfected or transduced with the gene
10/02/2003US20030185794 Such as a pleiotrophin or midkine molecule in a pharmaceutically acceptable carrier.
10/02/2003CA2756798A1 (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
10/02/2003CA2480385A1 Alkoxypyridine derivatives as nitric oxide synthase inhibitors
10/02/2003CA2480384A1 Phenanthridinones as parp inhibitors
10/02/2003CA2480302A1 Compositions and methods for treating and preventing necrosis
10/02/2003CA2480039A1 Spiro derivatives and adhesion molecule inhibitors comprising the same as active ingredient
10/02/2003CA2479880A1 Combination comprising an hmg-coa reductase inhibittor and an insulin secretor enhancer or an insulin sensitizer
10/02/2003CA2479722A1 Combination of an aldosterone receptor antagonist and a fibric acid derivative
10/02/2003CA2479671A1 Combination of an aldosterone receptor antagonist and nicotinic acid for a nicotinic acid derivative
10/02/2003CA2479338A1 Substituted phenylacetic acids
10/02/2003CA2479279A1 Fused bicyclic pyridine derivative as tachykinin receptor antagonist
10/02/2003CA2479277A1 Fused bicyclic pyrimidine derivatives
10/02/2003CA2479259A1 Combination of an aldosterone receptor antagonist and a bile acid sequestering agent
10/02/2003CA2479150A1 Heteroaromatic urea derivatives as vr-1 receptor modulators for treating pain
10/02/2003CA2478855A1 Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases
10/02/2003CA2478839A1 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003CA2478801A1 Method for administration of growth hormone via pulmonary delivery
10/02/2003CA2478327A1 Hgh (human growth hormone) formulations for pulmonary administration
10/02/2003CA2477651A1 Kinase inhibitors
10/01/2003EP1348709A2 Thiazolo (4,5-D) pyrimidine compounds
10/01/2003EP1348707A1 Pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
10/01/2003EP1348701A1 (2,4-disubstituted-thiazol-5-yl) amine compounds as PDE7 inhibitors
10/01/2003EP1348436A1 Meloxicam suppositories
10/01/2003EP1348434A1 Use of pyridyl amides as inhibitors of angiogenesis
10/01/2003EP1348433A1 Thiazol-2-yl-imine compounds as PDE-7 inhibitors
10/01/2003EP1347992A2 Polymorphic bone morphogenetic protein 2
10/01/2003EP1347990A2 Peptide mit inhibierender aktivität zur produktion von stickstoffmonoxid
10/01/2003EP1347986A2 Crystalline glucosamine sulphate metal salts and processes for preparing the same
10/01/2003EP1347976A2 Tricyclic purine compounds and their analogs as inhibiotrs of cytokine signalling
10/01/2003EP1347971A1 Thiazolyl inhibitors of tec family tyrosine kinases
10/01/2003EP1347968A1 Lfa-1 antagonist compounds
10/01/2003EP1347966A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
10/01/2003EP1347963A2 Benzofuran and benzothiophene derivatives as selective cox-2 inhibitors
10/01/2003EP1347959A1 Indole derivatives as ligands of thyroid receptors
10/01/2003EP1347766A2 Composition for the treatment of osteoarthritis
10/01/2003EP1347751A2 Methods of treating bone cancer and the pain associated therewith using endothelin antagonists
10/01/2003EP1204655B1 A crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride
10/01/2003EP1202954B1 Novel aminobenzophenones
10/01/2003EP1019434B1 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis
10/01/2003EP0998455B1 Dihomo-seco-cholestanes with two unsaturated bonds in the side chain
10/01/2003CN1446227A Novel fibroblast growth factor (FRF23) and method for use
10/01/2003CN1446214A Cinnoline compounds
10/01/2003CN1446202A 2-aminopyridine compounds and use thereof as drugs
10/01/2003CN1446197A Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
10/01/2003CN1446098A Modulation of alpha-6 integrin-mediated responses
10/01/2003CN1446093A Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compositions as bisphosphate delivery systems with reduced GI toxicity
10/01/2003CN1446086A Use of estramustine phosphate in treatment of bone metastasis
10/01/2003CN1446084A Treatment of insulin resistance syndrome
10/01/2003CN1444988A External plaster of sea horse and soft-shelled turtle
10/01/2003CN1444985A Oil for comforting channels and collaterals
10/01/2003CN1444984A Oil from trees
10/01/2003CN1444977A Medicine combination containing valid part of ÔÇÿRuyi Jinhuang SanÔÇÖ and its preparing method
10/01/2003CN1444969A Plaster for treating pain in neck, shoulder, waist and lower extremities
10/01/2003CN1444966A Medicine for promoting increase of bone substance
10/01/2003CN1444954A Boneset pills
10/01/2003CN1444939A Usage of total alkaloid of coftis root, phellodendron bark and ÔÇÿSankezhenÔÇÖ as their preparing method
10/01/2003CN1122657C Colchicine skeleton compounds, their use as medicaments and compounds containing them
10/01/2003CN1122520C Capsule for treating femoral head necrosis
09/2003
09/30/2003US6627774 N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them
09/30/2003US6627656 Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore
09/30/2003US6627637 I kappa B kinase inhibitors for treating various disorders including arthritis
09/30/2003US6627633 The compounds also are potent inhibitors of human cellular proliferation. As such, the compounds constitute pharmaceutical compositions with a pharmaceutically acceptable carrier. Such compounds are useful in inhibiting cellular
09/30/2003US6627626 Antiinflammation agents and antiarthritic agents colon cancer, and Alzheimer's disease in mammals, preferably humans, dogs, cats and livestock animals.
09/30/2003US6627602 Preventing desensitization of receptors
09/30/2003US6627221 Unit dose containing less than 5% by weight of stearic acid lubricant in the outer phase, relative to the total weight have good dissolution rate, heat resistance and storage stability for drugs such as ibandronate sodium
09/30/2003US6627195 Binding agents to CD23
09/30/2003CA2254750C Inhibition of matrix metalloproteases by 2-(.omega.-aroylalkyl)-4-biaryl-oxobutyric acids
09/25/2003WO2003078647A2 Aza-benzothiopyranoindazoles with antitumor activity
09/25/2003WO2003078632A1 Novel receptor polypeptides and polynucleotides encoding the same
09/25/2003WO2003078435A1 Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators
09/25/2003WO2003078427A1 Azolylaminoazines as inhibitors of protein kinases
09/25/2003WO2003078426A1 Azolylaminoazine as inhibitors of protein kinases
09/25/2003WO2003078425A1 Novel crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt
09/25/2003WO2003078421A1 Piperidine derivatives useful as modulators of chemokine receptor activity
09/25/2003WO2003078415A1 Cyclic hemiacetal derivative and use thereof
09/25/2003WO2003078404A1 Pyrimidine derivatives
09/25/2003WO2003078395A1 Piperidine derivatives useful as modulators of chemokine receptor activity
09/25/2003WO2003077947A1 Methods of modulating cd200 receptors
09/25/2003WO2003077921A1 Azinylaminoazoles as inhibitors of protein kinases
09/25/2003WO2003077919A1 Fluorinated 4-azasteroid derivatives as androgen receptor modulators
09/25/2003WO2003077915A1 Use of rapamycin for inhibiting of cell death
1 ... 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 ... 820